Is DMAA (1,3-dimethylamylamine) safe?
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Safety of DMAA (1,3-Dimethylamylamine)
Introduction to DMAA Safety Concerns
1,3-Dimethylamylamine (DMAA) is a stimulant commonly found in dietary and sports supplements. Its safety has been a subject of intense debate, leading to regulatory actions in various countries. This article synthesizes the current research on the safety profile of DMAA, focusing on its physiological effects, regulatory status, and reported adverse events.
Physiological Effects and Safety Profile
Chronic Supplementation Studies
A study involving 50 healthy men assessed the safety of chronic DMAA supplementation over 12 weeks. Participants were divided into groups receiving either a placebo, caffeine, DMAA, or a combination of caffeine and DMAA. The study measured various health markers, including body composition, blood pressure, and cardiac biomarkers. The results indicated no significant changes in these variables, suggesting that DMAA, alone or in combination with caffeine, did not produce harmful effects over the study period.
Acute and Long-term Harms
A critical review of studies on DMAA highlighted mixed findings regarding its safety. While some experimental studies reported increases in blood pressure and decreases in body weight and fat, the evidence base was considered shallow. Case studies involving emergency department visits showed that adverse effects often subsided after discontinuing DMAA use. However, the review emphasized the need for more robust research to determine safe dosage levels.
Regulatory Actions and Bans
FDA and International Bans
The United States Food and Drug Administration (FDA) has banned DMAA in dietary supplements, citing cardiovascular risks such as high blood pressure and heart attacks. Similar actions have been taken by regulatory agencies in other countries, including Australia and Brazil, due to concerns about DMAA's safety and potential for serious adverse effects .
Presence in Supplements
Despite regulatory bans, DMAA continues to be found in dietary supplements. Studies have identified DMAA and its analogs in various products, often at dosages higher than those previously approved for pharmaceutical use. This ongoing presence in the market underscores the challenges in enforcing bans and ensuring consumer safety .
Reported Adverse Events
Poison Center Reports
Data from Texas poison centers revealed 56 exposures to DMAA-containing products, with the majority of cases involving a product called OxyElite Pro™. Commonly reported symptoms included tachycardia, nausea, and vomiting. Most cases were managed on-site and classified as not serious, but the potential for more severe outcomes remains a concern.
Case Reports of Severe Outcomes
There have been reports of severe adverse events, including cardiac arrest and hemorrhagic stroke, associated with DMAA use. One case involved a 21-year-old man who suffered a cardiac arrest after consuming a DMAA-containing workout supplement. Such cases highlight the potential for serious harm, particularly in young, otherwise healthy individuals.
Conclusion
The safety of DMAA remains contentious, with studies showing both benign and harmful effects. While some research suggests that DMAA may be safe for short-term use in healthy individuals, regulatory agencies have banned its use due to potential cardiovascular risks. Continued surveillance and more rigorous research are needed to fully understand the safety profile of DMAA and to inform regulatory and clinical practices.
Sources and full results
Most relevant research papers on this topic